Switching to Rosuvastain Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

This study has been terminated.

( Slow enrollment [HIGH SCREEN FAILURE RATE] )

Study NCT00651378 Information provided by Schering-Plough

First Received: March 31, 2008 Last Updated: April 1, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	June 2005
Primary Completion Date:	June 2005 (Final data collection date for primary outcome measure)